fenton's reagent has been researched along with gallic acid in 4 studies
| Studies (fenton's reagent) | Trials (fenton's reagent) | Recent Studies (post-2010) (fenton's reagent) | Studies (gallic acid) | Trials (gallic acid) | Recent Studies (post-2010) (gallic acid) |
|---|---|---|---|---|---|
| 1,891 | 1 | 843 | 4,793 | 42 | 2,579 |
| Protein | Taxonomy | fenton's reagent (IC50) | gallic acid (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Tissue-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | 6.6 | |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | 6.6 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 4.03 | |
| Matrilysin | Homo sapiens (human) | 4.03 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 4.65 | |
| Alpha-synuclein | Homo sapiens (human) | 4.43 | |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 4.03 | |
| Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | 1.37 | |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 4.03 | |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 4.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolar, J; Pihlar, B; Radovic, T; Strlic, M | 1 |
| Acero, JL; Benitez, FJ; Garcia, C; Leal, AI; Real, FJ | 1 |
| Arumughan, C; Benherlal, PS | 1 |
| Bertone, E; Corazzari, I; Ferraris, S; Prenesti, E; Tomatis, M; Turci, F; Vernè, E | 1 |
4 other study(ies) available for fenton's reagent and gallic acid
| Article | Year |
|---|---|
Anti- and prooxidative properties of gallic acid in fenton-type systems.
Topics: Antioxidants; Free Radical Scavengers; Gallic Acid; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxyl Radical; Iron; Iron Chelating Agents; Kinetics; Oxidants; Oxidation-Reduction; Temperature | 2002 |
Gallic acid degradation in aqueous solutions by UV/H2O2 treatment, Fenton's reagent and the photo-Fenton system.
Topics: Gallic Acid; Hydrogen Peroxide; Hydrogen-Ion Concentration; Iron; Kinetics; Osmolar Concentration; Oxidation-Reduction; Photochemistry; Solutions; Ultraviolet Rays; Water; Water Pollutants, Chemical; Water Pollution, Chemical | 2005 |
Studies on modulation of DNA integrity in Fenton's system by phytochemicals.
Topics: Antioxidants; Apigenin; Ascorbic Acid; Bacteriophage lambda; Catechin; Cytoprotection; DNA Damage; DNA Fragmentation; Dose-Response Relationship, Drug; Flavanones; Gallic Acid; Genomic Instability; Hydrogen Peroxide; In Vitro Techniques; Iron; Models, Biological; Plant Extracts | 2008 |
Gallic acid grafting modulates the oxidative potential of ferrimagnetic bioactive glass-ceramic SC-45.
Topics: Biocompatible Materials; Body Fluids; Ceramics; Formates; Gallic Acid; Humans; Hydrogen Peroxide; Iron; Linoleic Acid; Lipid Peroxidation; Magnets; Microscopy, Electron, Scanning; Oxidation-Reduction; Reactive Oxygen Species; Spectrophotometry; Spectroscopy, Fourier Transform Infrared | 2016 |